Home>Topics>Drug Companies

Drug Companies

  1. All
  2. Commentary
  3. Stock Reports
  4. Video Reports
  5. Fund Reports
  6. ETF Reports
  7. Headlines
  1. Acura awarded NIDA grant to develop new abuse deterrent tech

    Headlines

    Wed, 27 Aug 2014

    The National Institute On Drug Abuse awards a $300K grant to Acura Pharmaceuticals (NASDAQ: ACUR ) to fund Phase 1 development of the company's Limitx abuse deterrent technology. Under the terms of the grant

  2. BRIEF-Shanghai Pharma's H1 net profit up 10.8 pct

    Headlines

    Wed, 27 Aug 2014

    Aug 27 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd

  3. We've scheduled your meeting but don't think for a minute that we've given up the fight

    Headlines

    Tue, 26 Aug 2014

    Central District of California for an expedited schedule for discovery and a preliminary injunction against Valeant Pharmaceuticals ( VRX +1.4% ) and Pershing Square Capital Management for violating insider trading laws. If successful, the

  4. Allergan, facing shareholder demands, calls special meeting for December 18

    Headlines

    Tue, 26 Aug 2014

    (Reuters) - Allergan Inc said on Tuesday that it has scheduled a special shareholders meeting for Dec. 18, when activist investor Bill Ackman, who supports a hostile bid for the company by Valeant Pharmaceuticals Inc, will attempt to oust most of its board.

  5. Allergan, facing shareholder demands, calls special meeting for Dec. 18

    Headlines

    Tue, 26 Aug 2014

    Aug 26 (Reuters) - Allergan Inc said on Tuesday that it has scheduled a special shareholders meeting for Dec. 18, when activist investor Bill Ackman, who supports a hostile bid for the company by Valeant Pharmaceuticals Inc, will attempt to oust most of its board.

  6. Cheap Canadian Drugs: Why?

    Headlines

    Tue, 26 Aug 2014

    business, pharmaceutical companies curb research ..... revenue. Pharmaceuticals fell back ..... could require drug manufacturers to sell drugs ..... force the drug companies to stop using ..... the world. Pharmaceutical companies would reject ..... development of pharmaceuticals or the delivery

  7. Allergan sets date for special shareholders meeting

    Headlines

    Tue, 26 Aug 2014

    In a filing response to the Delaware Chancery Court, Allergan ( AGN +0.3% ) discloses that it has set December 18, 2014 for the special shareholders meeting requested by Valeant Pharmaceuticals ( VRX +1.3% ) and Pershing Square. Post your comment!

  8. Newly Nasdaq-Listed Immune Pharma Offers Big Upside

    Headlines

    Tue, 26 Aug 2014

    By Jason Napodano, CFA : On August 14, 2014, Immune Pharmaceuticals , Inc. (NASDAQ: IMNP ) announced financial results for the second quarter 2014. For the quarter, the company reported no revenues

  9. Avanir clinical trial triggers milestone payment to Concert Pharma

    Headlines

    Tue, 26 Aug 2014

    The initiation of Avanir Pharmaceuticals ' ( AVNR +2% ) AVP-786 clinical trial for MDD triggers a $2M milestone payment to Concert Pharmaceuticals ( CNCE +5.1% ) as part of their license agreement for deuterium-modified dextromethorphan compounds. Post your comment!

  10. Avanir commences clinical trial for MDD med

    Headlines

    Tue, 26 Aug 2014

    Avanir Pharmaceuticals ( AVNR +1% ) initiates a Phase 2 study to evaluate the safety, tolerability and efficacy of AVP-786 for the adjunctive treatment

« Prev12345Next »
Content Partners